: Insulin growth factor-1 (IGF-1), an osteoclast-dependent osteolysis biomarker, contributes to metastatic bone cancer pain (MBCP), but the underlying mechanism is poorly understood. In mice, the femur metastasis caused by intramammary inoculation of breast cancer cells resulted in IGF-1 increase in femur and sciatic nerve, and IGF-1-dependent stimulus/non-stimulus-evoked pain-like behaviors. Adeno-associated virus-based shRNA selective silencing of IGF-1 receptor (IGF-1R) in Schwann cells, but not in dorsal root ganglion (DRG) neurons, attenuated pain-like behaviors. Intraplantar IGF-1 evoked acute nociception and mechanical/cold allodynia, which were reduced by selective IGF-1R silencing in DRG neurons and Schwann cells, respectively. Schwann cell IGF-1R signaling promoted an endothelial nitric oxide synthase-mediated transient receptor potential ankyrin 1 (TRPA1) activation and release of reactive oxygen species that, via macrophage-colony stimulating factor-dependent endoneurial macrophage expansion, sustained pain-like behaviors. Osteoclast derived IGF-1 initiates a Schwann cell-dependent neuroinflammatory response that sustains a proalgesic pathway that provides new options for MBCP treatment.
Schwann cell insulin-like growth factor receptor type-1 mediates metastatic bone cancer pain in mice / Landini, Lorenzo; Marini, Matilde; Souza Monteiro de Araujo, Daniel; Romitelli, Antonia; Montini, Marco; Albanese, Valentina; Titiz, Mustafa; Innocenti, Alessandro; Bianchini, Francesca; Geppetti, Pierangelo; Nassini, Romina; De Logu, Francesco. - In: BRAIN, BEHAVIOR, AND IMMUNITY. - ISSN 1090-2139. - ELETTRONICO. - 110:(2023), pp. 348-364. [10.1016/j.bbi.2023.03.013]
Schwann cell insulin-like growth factor receptor type-1 mediates metastatic bone cancer pain in mice
Landini, Lorenzo;Marini, Matilde;Souza Monteiro de Araujo, Daniel;Romitelli, Antonia;Montini, Marco;Albanese, Valentina;Titiz, Mustafa;Innocenti, Alessandro;Bianchini, Francesca;Geppetti, Pierangelo;Nassini, Romina;De Logu, Francesco
2023
Abstract
: Insulin growth factor-1 (IGF-1), an osteoclast-dependent osteolysis biomarker, contributes to metastatic bone cancer pain (MBCP), but the underlying mechanism is poorly understood. In mice, the femur metastasis caused by intramammary inoculation of breast cancer cells resulted in IGF-1 increase in femur and sciatic nerve, and IGF-1-dependent stimulus/non-stimulus-evoked pain-like behaviors. Adeno-associated virus-based shRNA selective silencing of IGF-1 receptor (IGF-1R) in Schwann cells, but not in dorsal root ganglion (DRG) neurons, attenuated pain-like behaviors. Intraplantar IGF-1 evoked acute nociception and mechanical/cold allodynia, which were reduced by selective IGF-1R silencing in DRG neurons and Schwann cells, respectively. Schwann cell IGF-1R signaling promoted an endothelial nitric oxide synthase-mediated transient receptor potential ankyrin 1 (TRPA1) activation and release of reactive oxygen species that, via macrophage-colony stimulating factor-dependent endoneurial macrophage expansion, sustained pain-like behaviors. Osteoclast derived IGF-1 initiates a Schwann cell-dependent neuroinflammatory response that sustains a proalgesic pathway that provides new options for MBCP treatment.File | Dimensione | Formato | |
---|---|---|---|
Landini BBI 2023.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
17.6 MB
Formato
Adobe PDF
|
17.6 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.